Skip to main content
Premium Trial:

Request an Annual Quote

GeneData Hires New CTO; Compugen Shuffles Board; and Others

NEW YORK, Aug. 8 - GeneData yesterday said it named Matthew Trunnell chief technology officer and head of the west coast office. The company also hired Dennis Bittner as its director of marketing.


Trunnell was previously director of technology synthesis at Blackstone Technology Group. Bittner previously was the alliance manager at InforMax.



Indian bioinformatics company Strand Genomics said on Monday it has tapped Siraj Dhanani as head of business development in the Asia-Pacific region, and Kas Kalyanasundaram as vice president of system biology.


Before joining the Strand, Siraj was an associate director at the health-care practice of UBS Warburg. Kalyanasundaram was senior biosystem engineer at Entelos.


Compugen said on Sunday that Amos Goren and Philip Young left its board of directors and that Eli Mintz will not be standing for re-election to the board.



Large Scale Biology recruited Charles Nash to its board of directors, the company said on July 31.


Nash is the principal of Nash Equity Capital, a strategic-consulting practice based in Atlanta.


He is succeeding Leigh Anderson, who resigned as a director at LSBC.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at [email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics, that appears every Wednesday.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.